APOBEC3B and neoplasm: Studies are currently underway to determine whether APOBEC3B-mediated mutagenesis is uniquely able to induce enhanced immunogenicity of tumor cell vaccines or whether other mutagenic compounds/processes—such as chemotherapy or radiation therapy—can have similar effects.